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Abstract
Background: Nasal bleeding remains one of the most common Head & Neck Surgical (Ear Nose
and Throat [ENT]/Oral & Maxillofacial Surgery [OMFS]) emergencies resulting in hospital
admission. In the majority of cases, no other intervention is required other than nasal packing, and
it was felt many cases could ideally be managed at home, without further medical interference. A
limited but national telephone survey of accident and emergency departments revealed that early
discharge practice was identified in some rural areas and urban departments (where adverse socio-
demographic factors resulted in poor patient compliance to admission or follow up), with little
adverse patient sequelae. A simple nasal packing protocol was also identified.
The aim of this audit was to determine if routine nasal haemorrhage (epistaxis) can be managed at
home with simple nasal packing; a retrospective and prospective audit.
Ethical committee approval was obtained. Similar practice was identified in other UK accident and
emergency centres. Literature was reviewed and best practice identified. Regional consultation and
feedback with regard to prospective changes and local applicability of areas of improved practice
mutually agreed upon with involved providers of care.
Methods: Retrospective: The Epistaxis admissions for the previous four years during the same
seven months (September to March).
Prospective: 60consecutive patients referred with a diagnosis of Nasal bleeding over a seven month
time course (September to March). All patients were over 16, not pregnant and gave fully informed
counselled consent.
New Guidelines for the management of nosebleeds, nasal packing protocols (with Netcel®) and
discharge policy were developed at the Hospital. Training of accident and emergency and
emergency ENT staff was provided together with access to adequate examination and treatment
resources. Detailed patient information leaflets were piloted and developed for use.
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BMC Surgery 2007, 7:19 http://www.biomedcentral.com/1471-2482/7/19Results: Previously all patients requiring nasal packing were admitted. The type of nasal packing
included Gauge impregnated Bismuth Iodoform Paraffin Paste, Nasal Tampon, and Vaseline gauge.
Over the previous four year period (September to March) a mean of 28 patients were admitted
per month, with a mean duration of in patient stay of 2.67 days.
In the prospective audit the total number of admissions was significantly reduced, by over 70%, (χ2
= 25.05, df = 6, P < 0.0001), despite no significant change in the number of monthly epistaxis
referrals (χ2 = 4.99, df = 6, P < 0.0001). There was also a significant increase in the mean age of
admitted patients with epistaxis (χ2 = 22.71, df = 5, P < 0.0001), the admitted patients had a mean
length of stay of 2.53 days. This policy results is an estimated saved 201.39 bed days per annum
resulting in an estimated annual speciality saving of over £50,000, allowing resource re-allocation
to other areas of need. Furthermore, bed usage could be optimised for other emergency or
elective work.
Conclusion: Exclusion criteria have now been expanded to exclude traumatic nasal haemorrhage.
New adjunctive therapies now include direct endoscopic bipolar diathermy of bleeding points, and
the judicious use of topical pro-coagulant agents applied via the nasal tampon. Expansion of the
audit protocols for use in general practice.
This original audit informed clinical practice and had potential benefits for patients, clinicians, and 
provision of service. Systematic replication of this project, possibly on a regional and general 
practice basis, could result in further financial savings, which would allow development of improved 
patient services and delivery of care.
Background
One of the biggest threats to waiting list times is the habit-
ual occupancy of beds by emergency admissions. We
wished to determine if surgical audit would have utility in
improving local surgical care in the management of
epistaxis and reduce unnecessary admission rate. Nasal
bleeding remains one of the most common ENT and
OMFS emergencies resulting in hospital admission [1],
quoted approximately at 30 per 100000 adults [2]. Its
cause tends only to be identified in 15% of patients, the
remainder classified as idiopathic. In the majority of cases
no other intervention is required other than nasal pack-
ing, and it was felt many cases could ideally be managed
at home, without further medical interference. In fact,
before the introduction of the National Health Service
(NHS), epistaxis was largely managed at home with only
the most severe cases referred for admission [3,4].
A telephone survey of several UK accident and emergency
departments revealed that early discharge practice in some
rural areas (Isle of Wight) and urban departments (Leeds),
where presumably adverse socio-demographic factors
may have resulted in poor patient compliance to admis-
sion or follow up, with little adverse patient sequelae. Lit-
erature on epistaxis management was reviewed [5,6] and
best practice identified [7-10]. It was determined that sim-
ple nasal packing was the only required medical interven-
tion in the vast majority of cases of nosebleeds not
responding to first aid measures. Furthermore, a simple
but efficacious non-specialist nasal packing protocol was
also identified [7-9]. Regional consultation and feedback
with regard to prospective changes and local applicability
of areas of improved practice mutually agreed upon with
involved providers of care (General Practitioners [GPs],
Accident & Emergency [A&E] Staff, ENT and OMF Sur-
geons) was undertaken. Research and development, local
ethics committee and hospital audit committee approval
was subsequently granted.
Methods
Detailed reviews of past Nasal Haemorrhage admissions
for the previous four years was undertaken in the form a
review of notes, admission details and bed usage.
New Guidelines for Epistaxis management and nasal
packing protocols using nasal tampons (e.g. Netcel® Poly-
vinyl alcohol sponge) and discharge policies were devel-
oped in the ENT, OMFS and A&E Departments. Training
of A&E and ENT/OMFS staff was provided together with
access to adequate examination and treatment resources.
Detailed patient information leaflets were piloted and
developed for use. The audit trial was conducted for 7
months (September to March) and compared to data col-
lected during the same time interval over (September to
March)the last 4 years to adjust for seasonal variations in
presentation and admission. The study group consisted of
all patients over 16, who were not pregnant and who gave
fully informed counselled consent. 60consecutive
patients were referred to the ENT Department with a diag-
nosis of Epistaxis over a seven-month time course (Sep-
tember to March) who matched the inclusion criteria.
They either presented to the A&E Department or referredPage 2 of 6
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A&E or the ENT staff of other hospitals were excluded.
A proforma was created for the A&E Department regard-
ing the management of epistaxis, which was enacted by
both the medical personnel and the emergency nurse
practitioners. All epistaxis patients were resuscitated as
required according to the Advanced Trauma Life Support
(ATLS) protocol. First aid measures were instituted i.e.
pinching the whole of the cartilaginous tip of the nose for
30 minutes followed by another 30 minutes of pressure
and pack of ice on bridge of nose if bleeding continued. If
the epistaxis persisted, blood and clot was removed to try
and visualize the bleeding vessel. Cautery was then
attempted. In the event the bleeding continued, local
anaesthetic in the form of Lidocaine Hydrochloride 5%
and Phenylephrine Hydrochloride 0.5% was sprayed into
the nose, left for 5–10 minutes and Netcell® nasal pack
was inserted into the nose and to the other side as well if
necessary.
The pack was lubricated with KY Jelly prior to insertion
and activated by 10–15 mls of cold tap water. They were
then observed for at least 30 minutes. Failure of cessation
of bleeding by this time is an absolute criterion for referral
to the ENT team for possible admission. The other abso-
lute criteria included shock, nasal packing within the last
7 days, anticoagulant medication, Haemoglobin of less
than 10 g/dl and uncontrolled hypertension. There were
also relative criteria for referral e.g. home more than 20
minutes away from the hospital, attendance to the hospi-
tal with epistaxis within the last 24 hours, living alone, no
car or telephone and if unhappy to be discharged. A con-
tact name and number was supplied on discharge.
Monthly audit of proforma and patient outcomes was
also undertaken during the audit to identify problem
areas.
Re-evaluation
One patient had to be excluded after being inadequately
packed in the accident department and was subsequently
managed by bipolar diathermy in the ward and sent home
the same day.
Forty-four patients were allowed home with nasal pack-
ing. Fifteen patients had to be admitted on presentation;
of which 9 were admitted as they oozed persistently after
packing with Netcel, 1 was admitted after sustaining
trauma to the nose and 3 were not happy to be discharged.
One admission experienced vaso-vagal syncope in casu-
alty and was admitted by a locum Senior House Officer
(SHO) who was not aware of the study.
There were a total of 10 complications (Figure 3). Seven
patients had bloody nasal oozing between day one and
day two; of these 2 returned to the ward one of whom had
nasal cautery with AgNO3 and was allowed home, while
the other was admitted. Five patients reported bloody
nasal oozing at home, which stopped with first aid meas-
ures. At day two, one patient complained of symptoms
suggestive of early acute rhino-sinusitis which settled
spontaneously. There were 2 patients with complication
after day two, of these one patient did not get an advice
sheet and only came back to have the pack removed at day
7, whilst the other patient had recurring minor epistaxis
after pack removal. This patient was a healthy non com-
pliant 18 years old male who had traumatic epistaxis 3
days prior to presentation. He was appropriately packed
and given the advice sheet and allowed home. His Hae-
moglobin at presentation was 13.5 g/dl, the next day he
had pack removal with no further bleeding but at day 3 he
returned with recurrent minor epistaxis. Unfortunately he
refused further packing and admission. He was seen in
clinic at day 6 and was found to be anaemic with Haemo-
globin of 7.3 g/dl. He was counselled and subsequently
received a blood transfusion and did not experience any
further epistaxis. As a result of these complications the
exclusion criteria and treatment sheets for the audit were
modified.
Results
Previously all patients requiring nasal packing were
admitted. The type of nasal packing included Gauze
impregnated Bismuth Iodoform Paraffin Paste (BIPP),
Nasal Tampon, and Vaseline gauze. During the previous
four years and over the same 7 month period (September
to March) a mean of 28 patients were admitted per
month, with an average in patient stay of 2.67 days.
The method of nasal packing was well tolerated by
patients with over 76% of patients having a visual ana-
logue pain score of 6/10 or less at insertion. There were no
patient complaints with regard to the discharge policy.
Analysis by a Wilcoxon signed rank test suggested a signif-
icant difference (p < .01) between the number of admis-
sions between the audit protocol group and standard
admission policy group (Figure 1). In this prospective
audit the total number of admissions was significantly
reduced by 73% (χ2 = 25.05, df = 6, P < 0.0001), despite
Table 1: The patients' demographics
Demographics Discharged Admitted
Number (%) 73 27
Age (mean years) 67 72
Male :Female (n) 29:15 6:10
Using Anticoagulation 34% 56%
Pulse (mean) 86 bpm 91 bpm
Systolic BP 159 156
Diastolic BP 91 93Page 3 of 6
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(χ2 = 4.99, df = 6, P < 0.0001) (Figure 2). There was also a
significant increase in the mean age of admitted patients
with epistaxis (χ2 = 22.71, df = 5, P < 0.0001), the admit-
ted patients had a mean length of stay of 2.53 days (Table
1). This policy has resulted in an estimated 201.39 saved
bed days per annum for the hospital resulting in an esti-
mated annual saving of over £52,632, allowing resource
re-investment and re-allocation to other areas of need.
Further audit spiral
We now formally require patient's signature on the treat-
ment sheet to indicate that they have read and understood
the advice sheet. Exclusion criteria have now been
expanded to exclude traumatic epistaxis that does not
cease bleeding after simple first aid measures (Figure 3).
New adjunctive therapies now include direct endoscopic
bipolar diathermy of bleeding points [9,10], and the judi-
cious use of topical pro-coagulant agents applied via the
nasal tampon. Expansion of the audit protocols for use in
general practice is also underway.
Discussion
The vast majority of cases of epistaxis are dealt by A&E per-
sonnel or the ENT/OMFS SHOs with little experience.
Nasal packing with a nasal tampon or similar material is
the technique of choice for these personnel [5]. Netcell®
nasal pack was chosen over BIPP because was reported to
be easier to use and insert than BIPP in inexperienced
hands. The technique involved for effective packing
requires minimal skill and ENT knowledge. It can be
inserted blindly without the need for special equipment
or adequate lighting. The pack is made of Polyvinyl Alco-
hol, which reportedly promotes platelet aggregation, and
does not support bacterial or fungal growth. It is fibre-free
and this minimises trauma to the nasal mucosa. It is less
complicated and more acceptable to both patients and
A&E personnel and avoids iodine allergy or intolerance.
Importantly there is no significant difference in term of
effectiveness in arresting epistaxis.
Tranexamic acid was used as an adjunct in some patients
with persistent ooze. It was injected directly into the pack.
It is primarily used in intravenously in patients with
intractable menorrhagia. The evidence in epistaxis is still
only anecdotal at present. In our study it seemed to have
helped stem the bleeding in all the three cases it was used.
We did not routinely prescribe antibiotic. In the face of
increasing antibiotic resistance and lack of evidence to
show that routine antibiotic in epistaxis patients with
nasal pack in-situ for less than 48 hours makes any differ-
ence, we felt this was inappropriate.
Anticoagulation did not appear to be a barrier to discharge
management if the level of anticoagulation was within the
therapeutic goal for the patients and his pre-existing
Total of monthly referrals and admissions with epistaxis dur-ing udit study over the 7-month (September-March) inter-vention time intervalFi ure 2
Total of monthly referrals and admissions with epistaxis dur-
ing audit study over the 7-month (September-March) inter-
vention time interval. It should be noted that previously 
nearly all referrals of epistaxis patients requiring packing had 
to bee admitted. It can be seen that this was not the case for 
the study period.
Number of monthly admissions with nasal haemorrhage in the standard (mean monthly admissio s over the previous 4 years; sm ll square points) and audit study (small t iangular points) over the 7-m nth (September-M rch) time interval allow f r easo al variatiFigur  1
Number of monthly admissions with nasal haemorrhage in 
the standard (mean monthly admissions over the previous 4 
years; small square points) and audit study (small triangular 
points) over the 7-month (September-March) time interval 
to allow for seasonal variations. This shows a significant 
reduction in the numbers of admissions.Page 4 of 6
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nant in deciding whether patients were going to be admit-
ted or not. Age did seem to be an important predictive
factor for admission. We compared the age difference of
the persistent bloody nasal dischargers in the admitted
group with those sent home. Those whom were deemed
to be safe to be sent home had an average age of almost a
decade younger (66.3). Blood pressure on presentation
however did not seem to be much different in the two
groups mentioned.
There was only 1 significant complication in this study,
requiring readmission and formal surgical cautery. This
was mainly due to the patient not being fully compliant
(Figure 3). The key to the success of the study appeared to
be the advice sheet, this contained advice on how to min-
imise recurrence of epistaxis and on what to do if the
epistaxis persist despite first aid steps.
Forty-four patients (73%) were safely managed at home
with Netcell® nasal packs and avoided admissions. In our
hospital the average length of admission for epistaxis was
2.67 days and thus projecting annually, potentials of
201.39 bed days were saved.
Conclusion
After careful assessment and provided that the patient's
nose is properly packed with a nasal sponge tampon and
advice sheet is given and understood, we believe it is safe
to manage selected patients with routine epistaxis at
home.
We feel that surgical audit does have utility in improving
local surgical care in the treatment of epistaxis. This origi-
nal audit informed our clinical practice and had potential
benefits for patients, clinicians, and provision of service.
We hope that a systematic replication of this project, pos-
sibly on a regional and general practice basis, could result
in further financial savings, which would allow develop-
ment of improved patient services and delivery of care.
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Review of the complications encountered in patients who underwent nasal packing and who were allowed homeFigure 3
Review of the complications encountered in patients who underwent nasal packing and who were allowed home. Nearly all the 
patients could be managed on an outpatient or 'office' basis. Unfortunately, one patient who suffered a nosebleed after an alco-
hol related trauma had to be admitted because a failure of compliance. We subsequently revised the treatment protocol after 
a multi-disciplinary meeting to exclude traumatic epistaxis where management may have to be surgical in the case of vessel 
retraction following fracture transaction.Page 5 of 6
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